Clover Corporation (ASX:CLV) has delivered a robust financial performance for the first half of 2026.
The nutritional ingredient specialist reported a first-half revenue of $44.1 million, representing a $6.5 million increase over the previous year.
The growth was primarily driven by sustained momentum across Europe and the Australia-New Zealand regions, where the company onboarded new customers while expanding its existing accounts.
The company’s bottom line showed even more impressive momentum.
Net profit after tax climbed to $4.2 million, up from $2.4 million in H1 FY25.
The profitability surge was bolstered by a dramatic expansion in gross margins, which rose to 35.6%—an 850-basis point improvement attributed to a more favourable product mix and enhanced manufacturing efficiencies.
EBITDA followed a similar trajectory, reaching $6.9 million.
CEO Peter Davey noted that the results reflect years of intensive research and development aimed at diversifying Clover's portfolio.
By expanding into broader segments such as senior, toddler, and adult nutrition, the firm has reduced its reliance on any single end market.
Clover issued confident revenue guidance for the full year of $82 million to $86 million.
The board has declared an interim dividend of 1 cent per share.
At the time of reporting, Clover Corporation's share price was $0.87.